FibroBiologics, Inc. Basic Shares Outstanding (Weighted Average)
FibroBiologics, Inc. (FBLG) reported Basic Shares Outstanding (Weighted Average) of 6.27 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-31
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.27M shares, a 224.71% increase year-over-year.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 3.77M shares, a 105.76% increase year-over-year.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 60.18M shares, a 76.33% increase year-over-year.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 43.07M shares, a 28.51% increase year-over-year.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 44.66M shares, a 35.85% increase from fiscal 2024.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 32.88M shares, a 16.45% increase from fiscal 2023.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 28.23M shares, a 0.00% change from fiscal 2022.
- FibroBiologics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 28.23M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 6.27M shares 10-Q · filed 2026-07-31 | 5.03M shares 10-Q · filed 2026-07-31 | 23.41M shares derived: average of 3 quarters · filed 2026-07-31 | 28.32M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2026-03-31 | 3.77M shares 10-Q · filed 2026-04-30 | 31.98M shares derived: average of 2 quarters · filed 2026-04-30 | 35.67M shares derived: average of 3 quarters · filed 2026-04-30 | 27.24M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2025-12-31 | 60.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 51.63M shares derived: average of 2 quarters · filed 2026-02-24 | 35.06M shares derived: average of 3 quarters · filed 2026-07-31 | 44.66M shares 10-K · filed 2026-02-24 | ||
| 2025-09-30 | 43.07M shares 10-Q · filed 2025-10-31 | 22.50M shares derived: average of 2 quarters · filed 2026-07-31 | 39.49M shares 10-Q · filed 2025-10-31 | 20.24M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2025-06-30 | 1.93M shares 10-Q · filed 2026-07-31 | 38.64M shares 10-Q · filed 2025-07-31 | 1.88M shares 10-Q · filed 2026-07-31 | 37.67M shares 10-Q · filed 2025-07-31 | 12.63M shares derived: average of 3 quarters · filed 2026-07-31 | 17.85M shares derived: average of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | 1.83M shares 10-Q · filed 2026-04-30 | 36.67M shares 10-Q · filed 2025-05-14 | 17.98M shares derived: average of 2 quarters · filed 2026-04-30 | 23.16M shares derived: average of 3 quarters · filed 2026-04-30 | 25.55M shares derived: average of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | 34.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 33.82M shares derived: average of 2 quarters · filed 2026-02-24 | 33.45M shares derived: average of 3 quarters · filed 2026-02-24 | 32.88M shares 10-K · filed 2026-02-24 | ||
| 2024-09-30 | 33.52M shares 10-Q · filed 2025-10-31 | 33.12M shares derived: average of 2 quarters · filed 2025-10-31 | 32.46M shares 10-Q · filed 2025-10-31 | 31.40M shares derived: average of 4 quarters · filed 2025-10-31 | ||
| 2024-06-30 | 32.72M shares 10-Q · filed 2025-07-31 | 31.93M shares 10-Q · filed 2025-07-31 | 30.69M shares derived: average of 3 quarters · filed 2025-07-31 | 30.08M shares derived: average of 4 quarters · filed 2025-07-31 | ||
| 2024-03-31 | 31.13M shares 10-Q · filed 2025-05-14 | 29.68M shares derived: average of 2 quarters · filed 2025-05-14 | 29.20M shares derived: average of 3 quarters · filed 2025-05-14 | 28.96M shares derived: average of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | 28.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 28.23M shares derived: average of 2 quarters · filed 2025-03-31 | 28.23M shares derived: average of 3 quarters · filed 2025-03-31 | 28.23M shares 10-K · filed 2025-03-31 | ||
| 2023-09-30 | 28.23M shares 10-Q · filed 2024-11-12 | 28.23M shares derived: average of 2 quarters · filed 2024-11-12 | 28.23M shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 28.23M shares 10-Q · filed 2024-08-07 | 28.23M shares 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | 28.23M shares 10-Q · filed 2024-05-14 | |||||
| 2022-12-31 | 28.23M shares 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |